Thursday, November 21, 2024
Subscribe American Journal of Medicine Free Newsletter
medical educationCMEFree CME Webcast on Pain Management

Free CME Webcast on Pain Management

spine-rendering-stockEvery day, approximately 113 people die from a drug overdose in the United Sates. According to the Centers for Disease Control (CDC), 74% of the 22,810 deaths attributed to drug overdoses in 2011 involved opioid pain relievers or prescription painkillers.[i] Moreover, in 2007, prescription opioid abuse cost the United States 55.7 billion dollars, an amount that includes job loss and incarceration. Overdoses are far more likely to occur in otherwise healthy individuals, and they are a leading cause of accidental death in young people. The morbidity and mortality of this disease are disproportionally high in terms of economic cost and emotional burden on survivors and their families. Given the immense toll that this disease takes on the lives of patients, caregivers, and society, it is critical for healthcare providers to understand how to screen for potentially at-risk patients, quickly diagnose those who are overdosing, and effectively treat patients when they see them in the hospital or ambulatory setting.

Naloxone, the antidote to opioid drugs, is an extremely effective agent with minimal side-effects. However, this medication is not being used as effectively as necessary, and it is not as readily available as it should be to save lives. In addition, healthcare providers do not know enough about naloxone, and patients who are overdosing outside a hospital setting do not always have timely access to the medication.

Naloxone: The Universal Antidote fof Opioid Overdose CME activity is to explain how healthcare providers can use screening and diagnostic tools to effectively identify high-risk patients and patients who present with an overdose. It will also review the appropriate treatments for opioid overdose. Lastly, this activity will examine barriers to access and review how healthcare providers can educate at-risk patients and their families about opioid safety, overdose reversal and how to administer naloxone at home.

Learning Objectives for this Activity:

Upon completion of this activity, the participant should be able to:

  • Identify patients at increased risk for opioid overdose and diagnose patients presenting with drug overdoses, including those patients with respiratory and central nervous system depression
  • Evaluate recently developed treatments for opioid overdoses and their potential use by at-risk individuals and their families
  • Educate patients and caretakers about how to administer naloxone, how to re-evaluate the patient as the naloxone wears off, and how to inform emergency personnel of known or suspected opioid overdose

To learn move about Naloxone and to register for this CME activity, go here.

Related…

The American Journal of Medicine website also has a REMS Resource Center with provides tools for safe prescribing in chronic pain management. Check out this other CME activity here.

 

Latest Posts

lupus

Sarcoidosis with Lupus Pernio in an Afro-Caribbean Man

A 54-year-old man of Afro-Caribbean ancestry presented with a 2-month history of nonproductive cough, 10-day history of constant subjective fevers, and a 1-day history...
Flue Vaccine

Flu Vaccination to Prevent Cardiovascular Mortality (video)

0
"Influenza can cause a significant burden on patients with coronary artery disease," write Barbetta et al in The American Journal of Medicine. For this...
varicella zoster

Varicella Zoster Virus-Induced Complete Heart Block

0
Complete heart block is usually caused by chronic myocardial ischemia and fibrosis but can also be induced by bacterial and viral infections. The varicella...
Racial justice in healthcare

Teaching Anti-Racism in the Clinical Environment

0
"Teaching Anti-Racism in the Clinical Environment: The Five-Minute Moment for Racial Justice in Healthcare" was originally published in the April 2023 issue of The...
Invisible hand of the market

The ‘Invisible Hand’ Doesn’t Work for Prescription Drugs

0
Pharmaceutical innovation has been responsible for many “miracles of modern medicine.” Reliance on the “invisible hand” of Adam Smith to allocate resources in the...
Joseph S. Alpert, MD

New Coronary Heart Disease Risk Factors

0
"New Coronary Heart Disease Risk Factors" by AJM Editor-in Chief Joseph S. Alpert, MD was originally published in the April 2023 issue of The...
Cardiovascular risk from noncardiac activities

Cardiac Risk Related to Noncardiac & Nonsurgical Activities

0
"Assessment of Cardiovascular Risk for Noncardiac and Nonsurgical Activities" was originally published in the April 2023 issue of The American Journal of Medicine. Cardiovascular risk...